As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
via Google News
The Latest on: Breast cancer diagnosis
- Prognostic tests and how it can impact breast cancer treatmenton September 16, 2021 at 9:51 pm
Dr Aditi Thanky, Consultant Medical Oncologist and Haematologist at Sterling Hospital, Rajkot talks about breast cancer treatment and role of prognostic tests ...
- After winning her breast cancer battle, a Findlay woman is now fighting for otherson September 16, 2021 at 7:33 pm
Getting a breast cancer diagnosis is some of the worst news you can get, but imagine having to deal with it during a pandemic, away from your family and friends. That's what Kim Peplinski of Findlay ...
- What Is Metastatic Breast Cancer? Doctors Explain the Advanced Form of the Diseaseon September 14, 2021 at 3:34 pm
Up to 30% of patients with early-stage breast cancer will go on to develop a metastatic form of the disease—here's what to know.
- 10 Breast Cancer Myths You Need To Clear Up Right Nowon September 14, 2021 at 1:30 pm
That’s why the same treatment program doesn’t work for everyone. Your genes can also determine how quickly your cancer progresses. If you’re diagnosed with breast cancer, your doctor will carry out ...
- 'Born to save my life': How a Bartlett woman's breast cancer diagnosis helped save her momon September 13, 2021 at 11:41 am
Sleeping in a bra helped unravel a lineage of breast cancer genes for Karen Boyd's family. Now, she's working to help others battling breast cancer.
- What do the different stages of breast cancer mean? Which is the most dangerous?on September 11, 2021 at 4:01 am
Sen. Amy Klobuchar's breast cancer diagnosis has put a spotlight on the disease. But the stages can be hard to decipher.
- Breast Cancer Diagnosis in the ‘Between’ Year: Body Mass Index Matteron September 9, 2021 at 12:49 pm
While mammograms reduce breast cancer mortality by 15-20%, the diagnosis in many cases—approximately 15% of all breast cancers—occurs after a patient has a negative mammogram and before her next ...
- Sen. Amy Klobuchar says she was diagnosed and treated for breast cancer this yearon September 9, 2021 at 10:05 am
Klobuchar used her announcement to urge Americans to not delay physicals and routine examinations because of the COVID-19 pandemic — as she had.
- Sen. Amy Klobuchar reveals breast cancer diagnosis, successful treatmenton September 9, 2021 at 9:44 am
The Minnesota Democrat said the cancer was found in a routine mammogram, which she acknowledged delaying because of the pandemic.
via Bing News